Impact of ciprofloxacin in the human-flora-associated (HFA) rat model: comparison with the HFA mouse model.

[1]  M. Bartholomew,et al.  Impact of residual and therapeutic doses of ciprofloxacin in the human-flora-associated mice model. , 2005, Regulatory toxicology and pharmacology : RTP.

[2]  Kiyoshi Yamaoka,et al.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations , 1978, Journal of Pharmacokinetics and Biopharmaceutics.

[3]  R. Carman,et al.  Ciprofloxacin at low levels disrupts colonization resistance of human fecal microflora growing in chemostats. , 2004, Regulatory toxicology and pharmacology : RTP.

[4]  P. Brandt,et al.  Evaluation of certain food additives. Joint FAO/WHO Expert Committee on Food Additives. Fifty-ninth report of the JECFA, nitrate and nitrite , 2002 .

[5]  J. Poul,et al.  Evaluation of residual and therapeutic doses of tetracycline in the human-flora-associated (HFA) mice model. , 2001, Regulatory toxicology and pharmacology : RTP.

[6]  C E Nord,et al.  Effect of antimicrobial agents on the ecological balance of human microflora. , 2001, The Lancet. Infectious diseases.

[7]  A. Servin,et al.  Escherichia coli strains colonising the gastrointestinal tract protect germfree mice againstSalmonella typhimuriuminfection , 2001, Gut.

[8]  H. Oh,et al.  Ecological Disturbances in Intestinal Microflora Caused by Clinafloxacin, an Extended-Spectrum Quinolone , 2000, Infection.

[9]  C. Nord,et al.  Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections. , 2000, The Journal of antimicrobial chemotherapy.

[10]  E. Goldstein,et al.  Comparative Activity of Moxifloxacin in Vitro Against Obligately Anaerobic Bacteria , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[11]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[12]  C. Thornsberry.  The In Vitro Antibacterial Activity of Quinolones: A Review , 1998 .

[13]  G. Stein,et al.  Pharmacokinetics and pharmacodynamics of newer fluoroquinolones. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  L. Drago,et al.  Impact of rufloxacin and ciprofloxacin on the intestinal microflora in a germ-free mice model. , 1995, Chemotherapy.

[15]  S. Salminen,et al.  Gut flora in normal and disordered states. , 1995, Chemotherapy.

[16]  Claude Carbón,et al.  Intestinal elimination of ciprofloxacin in rabbits , 1994, Antimicrobial Agents and Chemotherapy.

[17]  G. Corthier,et al.  Barrier effect of normal microbiota against Clostridium difficile may be influenced by drugs devoid of antibiotic activity , 1994 .

[18]  A. Benini,et al.  Bacterial Faecal Flora in Healthy Women of Different Ages , 1993 .

[19]  P. Javorskỳ,et al.  Resistance of ruminal microorganisms to supermethrin. , 1993, Veterinary and human toxicology.

[20]  T. Mitsuoka.  Intestinal flora and aging. , 2009, Nutrition reviews.

[21]  L. Gentry,et al.  Ecological effects of short-term ciprofloxacin treatment of travellers' diarrhoea. , 1992, The Journal of antimicrobial chemotherapy.

[22]  A. Janssen,et al.  The contribution of Escherichia coli to microbial colonization resistance. , 1990, The Journal of antimicrobial chemotherapy.

[23]  K. Wilson,et al.  Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora , 1988, Infection and immunity.

[24]  A. Andremont,et al.  Effect of oral ofloxacin on fecal bacteria in human volunteers , 1987, Antimicrobial Agents and Chemotherapy.

[25]  M. Rozenberg-Arska,et al.  Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora. , 1985, The Journal of infectious diseases.

[26]  I. Rowland,et al.  The effect of diet on the mammalian gut flora and its metabolic activities. , 1985, Critical reviews in toxicology.

[27]  D. Reeves,et al.  In-vitro studies with ciprofloxacin, a new 4-quinolone compound. , 1984, The Journal of antimicrobial chemotherapy.

[28]  H. Guiot.  Role of competition for substrate in bacterial antagonism in the gut , 1982, Infection and immunity.

[29]  S. Finegold,et al.  Effect of diet on human fecal flora: comparison of Japanese and American diets. , 1974, The American journal of clinical nutrition.

[30]  S. Gorbach,et al.  Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. , 1967, Gastroenterology.